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ABSTRACT: Oral rabies vaccination (ORV) campaigns have been conducted annually in the US over the
past two decades to prevent raccoon (Procyon lotor) rabies, which is enzootic along the eastern region
of the country from southeastern Canada to Alabama. Because raccoon rabies has been eliminated from
neighboring Canadian provinces, continued detection of the variant in the US is of concern due to the
potential for infected raccoons to cross the border via the St. Lawrence River. Ontario Rabies Vaccine
Baits (ONRAB) containing a live, recombinant human adenovirus expressing the rabies virus
glycoprotein have been under experimental use in the US since 2011. We distributed ONRAB in St.
Lawrence County, New York, from 2013 to 2015 as part of field trials to evaluate serologic responses in
raccoons. Prior to ONRAB distribution, rabies virus neutralizing antibody (RVNA) seroprevalence in
raccoons was 45.2% (183 of 405) and increased to 57.7% (165 of 286) after 3 yr of ONRAB baiting.
Postbait RVNA seroprevalence increased each year, with a lower response observed in juvenile
compared with adult raccoons. The pre-ONRAB seroprevalence detected in 2013 was relatively high
and was likely impacted both by elevated rabies activity in the county and the use of ORV with a
different vaccine bait for 14 consecutive years prior to our study. Tetracycline biomarker prevalence
increased from 1.4% prior to ONRAB baiting to 51.3% from 2013 to 2015, demonstrating bait
palatability to raccoons. These data complemented related field trials conducted in West Virginia and
the northeastern US.
Key words: Oral rabies vaccination, ONRAB, Procyon lotor, rabies, rabies virus neutralizing
antibodies, raccoon, St. Lawrence County.
INTRODUCTION
The St. Lawrence River not only serves as
an important waterway connecting the US and
Canada, but it also provides important ripar-
ian habitat for various wildlife species. The
corridor is heavily used by raccoons (Procyon
lotor), a ubiquitous mammal native to North
America, and the primary reservoir for
raccoon rabies virus in the eastern US
(Monroe et al. 2016). Rabid raccoons from
the enzootic area in St. Lawrence County,
New York (as supported by phylogenetic
data), have been identified in Ontario, Canada
(Rosatte et al. 2001; Nadin-Davis et al. 2006).
Despite coordinated oral rabies vaccination
(ORV) campaigns in the US and Canada to
prevent and control spread of the disease
(Slate et al. 2005; Rosatte et al. 2009a), cross-
border viral transmission along this corridor
remains a concern (Cullingham et al. 2009).
Within St. Lawrence County, New York,
specifically, ORV had occurred annually for
14 yr prior to our study, yet raccoon rabies
cases have continued to occur, suggesting the
need to evaluate different strategies, including
raccoon serologic responses to a different
vaccine bait.
Because raccoon rabies is considered enzo-
otic in St. Lawrence County and other parts of
New York, Vermont, and New Hampshire,
ORV had been conducted previously with
RABORAL V-RGt (V-RG; a registered trade-
mark in the US and elsewhere of Merial, Inc.,
now Boehringer Ingelheim, Athens, Georgia),
645
in an attempt to halt spread of the virus.
Ontario Rabies Vaccine Bait (ONRAB) is an
oral rabies vaccine bait that has been linked to
seroconversion rates of 66–84% in raccoons in
southwestern Ontario with bait densities
ranging from 75 to 400 baits/km2 (Rosatte et
al. 2009b). In a field trial conducted in
northern New York, Vermont, and New
Hampshire to evaluate the effectiveness of
targeting raccoons, a similar seroprevalence
(69%) to that reported in Ontario was
observed although different serologic tests
were used for analyzing samples (Gilbert et al.
2018).
Due to the importance of the St. Lawrence
River Valley as a potential corridor for
movement of rabid raccoons into Canada,
we evaluated the impact of ONRAB by
assessing rabies virus neutralizing antibody
(RVNA) seroprevalence and tetracycline bio-
marker response rates in raccoons prior to and
after ONRAB baiting in St. Lawrence County
from 2013 to 2015. Because ONRAB contains
a tetracycline biomarker that was not present
in the V-RG baits that had been distributed
prior to our study, the tetracycline response
data allowed for assessment of bait uptake in a
biomarker naı̈ve population.
MATERIALS AND METHODS
Study area
The study area was located near the St.
Lawrence River in St. Lawrence County, New
York, at 448410N, 758170W (Fig. 1). The design
consisted of two 127-km2 study cells (PBG09 and
PBG10) within a larger ORV zone separated by
5-km buffer zones (Fig. 1). Both study cells
were within an area that had been baited annually
at 75 baits/km2 with V-RG since 1999 and
consisted of similar habitat, including primarily
forest, agriculture, and wetlands or water based
on the 2011 National Land Cover Database
(Homer et al. 2015).
Bait and bait distribution
The Ontario Rabies Vaccine Bait (ONRAB
Ultralite baits, Artemis Technologies, Inc.,
Guelph, Ontario, Canada) consist of a polyvinyl
chloride blister pack containing 1.8 mL of the
human adenovirus recombinant rabies vaccine
coated with a dark green wax containing 100 mg
of tetracycline hydrochloride. The baits were
distributed in August each year (2013–15) by
fixed-wing aircraft along parallel flight lines at
750-m intervals at a target bait density of 75 baits/
km2 throughout the ORV zone (Fig. 1).
Trapping
Random points (34–36) were generated along
roadways each year for the four quadrants of each
study cell to guide trap placement by using
Hawth’s tools (Beyer 2012), and 25 of the points
were selected based on property access, permis-
sion to trap, and spatial distribution within the
cell. Four to six traps (depending on surrounding
habitat at the point) were placed within 800 m of
six of the selected points in three of the quadrants
and seven in the fourth quadrant, with a minimum
of 30.5 m between traps, for a total of 150 traps
per cell.
Trapping occurred annually for 10 consecutive
days approximately 2–4 wk prior to ORV in July
and August and again 4–5 wk after ORV in
September and October. Tomahawk live traps
(model 108; Tomahawk Live Trap, Hazelhurst,
Wisconsin, USA), baited with marshmallows and
anise oil (Minnesota Trapline Products, Inc.,
Pennock, Minnesota, USA), were used to trap
animals. Traps were checked daily and moved
every 2–3 d if no unique raccoons had been
captured.
Animal handling and sampling
All unique raccoons, striped skunks (Mephitis
mephitis), foxes (Vulpes vulpes and Urocyon
cinereoargenteus), coyotes (Canis latrans), and
fishers (Martes pennanti) captured during the
study were considered target animals due to their
importance as rabies vector species. All target
animals were anesthetized by intramuscular
injection of a 5:1 mixture of ketamine (10 mg/
kg) and xylazine (2 mg/kg) on the basis of
estimated body weight. While anesthetized,
weight, sex, and relative age were recorded, each
animal was uniquely numbered with an ear tag
(National Band and Tag Company, Newport,
Kentucky, USA), and approximately 5 mL of
blood was collected via a peripheral vein. A
premolar tooth was collected, whenever possible,
for age determination and biomarker (tetracy-
cline) analysis.
Animals were released at the point of capture
after sampling and upon recovery from anesthe-
sia, unless they were sick, acting strangely, or
seriously injured. These animals were euthanized
with carbon dioxide in accordance with the
American Veterinary Medical Association’s guide-
lines on euthanasia (Leary et al. 2013). All
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nontarget species were released at the point of
capture without anesthesia or sampling.
Laboratory testing
Serum samples were submitted to the New
York State Department of Health, Wadsworth
Laboratory (Slingerlands, New York, USA) to test
for RVNA by using a modified neutralization test
(Trimarchi et al. 1996). Sera with RVNA titers
0.125 IU/mL were considered positive, and sera
with RVNA titers ,0.125 IU/mL were considered
negative. Sera from 41 raccoons (2%) that could
not be evaluated at the cut-off value due to poor
sample quality were excluded from further
analyses. The entire heads from 11 euthanized
animals were sent to New York State Department
of Health for testing of brain tissue by direct
fluorescent antibody test (CDC 2005), and rabies
virus variant typing was performed on positive
samples (Szanto et al. 2011).
Age determination and biomarker analysis
Teeth were submitted to Matson’s Laboratory
LLC (Manhattan, Montana, USA) for age deter-
mination and biomarker analysis. Age was deter-
mined to the nearest year by using a compound
microscope and ultraviolet light with filters to
detect and count cementum or dentin annuli
(Johnston et al. 1999). Animals ,1 yr old were
classified as juveniles and those 1 yr as adults. If
a tooth was unavailable for aging (n¼43), the
relative age (juvenile or adult) determined at the
time of capture was used. Additionally, a thin
section of tooth was examined microscopically by
using an ultraviolet filter to detect fluorescence
indicative of tetracycline biomarker (Johnston et
al. 1999), typically visible 2 d after bait consump-
tion (Hanlon et al. 1989).
Data analysis
Unless otherwise specified, all further analyses
and results refer to raccoons because they were
FIGURE 1. Two study cells within a larger oral rabies vaccination zone where Ontario Rabies Vaccine Baits
(ONRAB) were distributed from 2013 to 2015, with the raccoon (Procyon lotor) rabies cases in the study area in
St. Lawrence County, New York, USA, reported by the New York State Department of Health from 2011 to 2018
(no cases were reported in the study area in 2011 or after 2015).
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the primary target species. We used a generalized
linear mixed model implemented in Program R,
package lme4 (Bates et al. 2015; R Development
Core Team 2017) to examine the RVNA sero-
prevalence and tetracycline prevalence in popu-
lations prior to and after baiting across the 3-yr
study. Year, trapping period (prebait or postbait),
age, and sex were considered fixed effects, and
study cell was considered a random effect. We
considered two relationships with seroprevalence
and year: a linear effect of year (representing a
trend in time, referred to as ‘‘trend’’) and each
year individually (to examine annual variability in
the effect on seroprevalence, referred to as
‘‘year’’). We examined models with simple main
effects, an additive model, and models with
relevant two-way interactions and compared these
to the null model. Models were compared by
using the second-order Akaike’s information
criterion (AICc), and models within two AICc of
the top model were considered competitive, with
model averaging being used when model uncer-
tainty occurred (Burnham and Anderson 2002).
RESULTS
Aerial baiting was conducted in northern
New York along the Canadian border with
356,550 ONRAB baits distributed at 75 baits/
km2 in the respective ORV zone from 2013 to
2015 (Fig. 1). Across the study cells, 39,385
baits were distributed, and actual bait densi-
ties for the ONRAB treatment area were 74,
78, and 75 baits/km2 for 2013, 2014, and 2015,
respectively.
A total of 1,474 unique raccoons were
captured, and 248 were recaptured. All
recaptures, with the exception of one raccoon,
were recaptured in the same study cell as they
were originally captured. The raccoon was a
naı̈ve juvenile male when originally sampled,
and 2 yr later was RVNA positive when
captured approximately 26 km from its
original location. The percentage of males
(54.1%) and females (45.8%) trapped during
the study was nearly the same, and 74% were
adults. One coyote, 10 fishers, one gray fox,
five red foxes, and 203 striped skunks were
also sampled; sera from the one coyote and 36
of the striped skunks tested RVNA positive
(Table 1).
The top model for RVNA seroprevalence
included two interactions: between year and
trapping period and between trapping period
and age (Table 2). The postbait RVNA
seroprevalence increased each year, whereas
the prebait seroprevalence varied annually
(Fig. 2). The postbait seroprevalence was
higher each year in adults compared with
juveniles (Fig. 2). Similarly, the postbait
seroprevalence in 2015 compared with the
prebait seroprevalence in 2013 was signifi-
cantly higher in adults but not in juveniles
(Fig. 2). The model estimates for postbait
seroprevalence of adults and juveniles for
2013, 2014, and 2015 were 57.6% (95%
confidence interval [CI]: 47.7–66.8), 61.6%
TABLE 1. The number of rabies antibody-positive sera and number of animals tested for each target species by
year and trapping period (prior to or after Ontario Rabies Vaccine Bait distribution) tested for rabies virus
neutralizing antibodies by using a modified virus neutralization test. Animals were captured in St. Lawrence
County, New York, USA, from 2013 to 2015.
Common name Scientific name
No. positive/no. tested
2013 2014 2015
Prebait Postbait Prebait Postbait Prebait Postbait
Coyote Canis latrans 0 0 0 0 0/1 0
Fisher Martes pennant 0/6 0/2 0/1 0 0/1 0
Gray fox Urocyon cinereoargenteus 0 0 0 0/1 0 0
Raccoona Procyon lotor 183/405 55/108 216/341 140/237 152/304 165/286
Red fox Vulpes vulpes 0 0 0 0 2/5 0
Striped skunka Mephitis mephitis 1/27 9/31 6/19 6/60 4/23 10/40
a Sera from 41 raccoons and three striped skunks could not be evaluated at the test cutoff.
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(95% CI: 54.6–68.3), and 63.7% (95% CI:
57.0–69.9), respectively. Sex was not an
important factor affecting RVNA seropreva-
lence.
The top model for tetracycline response
was the same as for the RVNA analysis (Table
3). The postbait tetracycline prevalence
among adults was higher than the prebait
prevalence for all years, with model estimates
of 1.4% (95% CI: 0.5–3.8) prior to ONRAB
baiting in 2013 compared with 51.3% (95%
CI: 43.9–58.5) after baiting in 2015 (Fig. 2).
The postbait tetracycline prevalence increased
each year among adults, but the biggest
change in juveniles was observed in 2015
(Fig. 2).
During the study, 11 raccoons were eutha-
nized and submitted for rabies diagnostic
testing. Three were rabid, and raccoon rabies
TABLE 2. Model results for rabies virus neutralizing
antibody seroprevalence response (titers .0.125 IU/
mL were considered positive) of a raccoon (Procyon
lotor) population sampled in St. Lawrence County,
New York, USA, from 2013 to 2015 prior to and after
baiting with Ontario Rabies Vaccine Baits.
Model testeda Kb DAICcc xd LLe
Year3periodþperiod
3age
9 0 0.98 128.34
Year3periodþage 8 9.02 0.01 134.38
Yearþperiodþage 6 10.41 0.01 137.89
Year3periodþsexþage 9 11.64 0 134.17
Yearþperiodþsexþage 7 12.71 0 137.67
Periodþage 4 18.45 0 144.47
Yearþage 5 20.33 0 144.16
Periodþsexþage 5 20.36 0 144.18
Trendþperiodþage 5 20.37 0 144.18
Trend3periodþage 6 22.35 0 143.86
Trendþperiodþsexþage 6 22.46 0 143.92
Trend3periodþsexþage 7 24.6 0 143.61
Trendþage 4 32.78 0 151.64
Age 3 33.57 0 153.22
Sexþage 4 35.71 0 153.1
Year 4 78.57 0 174.53
Yearþperiod 5 79.91 0 173.95
Year3period 7 80.72 0 171.67
Yearþsex 5 81.07 0 174.53
Yearþperiodþsex 6 82.52 0 173.95
Year3periodþsex 8 83.61 0 171.67
Trend 3 96.56 0 171.67
Trendþperiod 4 97.12 0 183.81
Period 3 98.32 0 185.6
Trendþsex 4 98.94 0 184.72
Intercept only 2 99.37 0 187.26
Trend3period 5 99.58 0 183.79
Trendþperiodþsex 5 99.6 0 183.8
Periodþsex 4 100.67 0 185.58
Sex 3 101.64 0 187.26
Trend3periodþsex 6 102.18 0 183.78
a period ¼ trapping period (prebait or postbait); trend ¼ linear
effect of year.
b K ¼ number of parameters.
c The second-order Akaike’s information criterion (AICc) for the
top model is 273.51. All models include a parameter for the
random effect of cell.
d x ¼ AICc model weight.
e LL ¼ log likelihood of the model.
FIGURE 2. The estimated seroprevalence of rabies
virus neutralizing antibodies (A) and biomarker
(tetracycline) prevalence (B) by age class of raccoons
(Procyon lotor) captured in St. Lawrence County,
New York, USA, prior to baiting with Ontario Rabies
Vaccine Baits compared with postbait distribution
each year in 2013–15. The 95% confidence intervals
are shown as vertical bars.
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was confirmed as the variant for those (Fig. 1).
All three were euthanized in 2013 because
they were exhibiting abnormal behavior; two
were collected during prebait and one during
postbait trapping.
DISCUSSION
Raccoon rabies has been detected in
Ontario and Quebec provinces, Canada, as
a result of infected raccoon movements
across the St. Lawrence River (Nadin-Davis
et al. 2006; Stevenson et al. 2016). Although
raccoon rabies activity in St. Lawrence
County has been relatively continuous, it is
not uniform throughout, as evident in our
study cells. Specifically, the number of rabies
cases reported in 2013 was much higher in
cell PBG10 compared with PBG09 (Fig. 1).
This local epizootic likely impacted the
prebait seroprevalence in 2013 within the
cell, as has been reported previously (Carey
and McLean 1983). As a result, the overall
impact of ONRAB baiting observed during
the study may have been diminished. Though
both study cells had been baited with V-RG
for 14 consecutive years prior to the study,
animals were not trapped prior to bait
distribution or routinely after baiting was
conducted; consequently, no data are avail-
able to examine trends in serologic response,
age structure, or temporal patterns. Despite
long-term baiting, an increase in RVNA
seroprevalence was observed after ORV
baiting with ONRAB. In a study conducted
in Virginia using V-RG, no difference was
observed after 3 yr when V-RG was applied
at 75 baits/km2 to an area that had previously
been baited for 12 yr (Pedersen et al. 2019).
Because the RVNA seroprevalence in our
study still indicated an increasing trend after
3 yr of baiting with ONRAB, it is possible
that the seroprevalence would have contin-
ued to increase if sampling had continued
(i.e., no saturation effect was observed).
However, additional sampling would have
been necessary to confirm this pattern. It also
suggested that application of ONRAB may
boost RVNA seroprevalence in raccoons
beyond levels achieved with V-RG (Gilbert
et al. 2018). The V-RG baiting prior to the
study obscured the relationship between the
serologic response and the tetracycline prev-
alence caused by consuming ONRAB baits.
Assuming the tetracycline prevalence in our
study was indicative of the response that
TABLE 3. Model results for biomarker (tetracycline)
prevalence response of a raccoon (Procyon lotor)
population sampled in St. Lawrence County, New
York, USA, from 2013 to 2015 prior to and after
baiting with Ontario Rabies Vaccine Baits.
Model testeda Kb DAICcc xd LLe
Year3periodeþperiod
3age
9 0 1 80.92
Year3period 7 53.94 0 110.85
Year3periodþage 8 55.3 0 110.09
Year3periodþsex 8 56.83 0 110.85
Year3periodþsexþage 9 58.32 0 110.07
Trendf3period 5 71.63 0 122.38
Trend3periodþage 6 72.12 0 121.32
Trend3periodþsex 6 74.24 0 122.38
Trend3periodþsexþage 7 74.82 0 121.29
Trendþperiod 4 83.27 0 129.45
Yearþperiod 5 83.91 0 128.53
Trendþperiodþage 5 84.52 0 128.83
Yearþperiodþage 6 85.59 0 128.05
Trendþperiodþsex 5 85.72 0 129.43
Yearþperiodþsex 6 86.49 0 128.5
Trendþperiodþsexþage 6 87.04 0 128.78
Yearþperiodþsexþage 7 88.25 0 128.01
Trendþage 4 164.11 0 169.87
Yearþage 5 166.6 0 169.87
Trend 3 179.75 0 178.89
Trendþsex 4 181.7 0 178.67
Year 4 181.94 0 178.79
Yearþsex 5 184 0 178.57
Period 3 241.43 0 209.72
Periodþsex 4 243.75 0 209.69
Periodþage 4 243.81 0 209.72
Periodþsexþage 5 246.25 0 209.69
Age 3 388.69 0 283.35
Sexþage 4 390.67 0 283.15
Intercept only 2 395.82 0 288.06
Sex 3 397.89 0 287.96
a period ¼ trapping period (prebait or postbait); trend ¼ linear
effect of year.
b K ¼ number of parameters.
c The second-order Akaike information criterion (AICc) for the
top model is 184.57. All models include a parameter for the
random effect of cell.
d x ¼ AICc model weight.
e LL ¼ Log likelihood of the model.
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would have been observed in an ORV naı̈ve
area, the increase in tetracycline prevalence
from ,1% to 54.2% after 3 yr of baiting
suggests ONRAB would have resulted in a
higher antibody prevalence if ORV had not
occurred previously. Even though a tetracy-
cline biomarker can be used to assess bait
consumption, it does not always signify
concurrent antibody development (Rosatte
et al. 2008) and can vary, depending on the
tissues selected for analysis (Algeo et al.
2013). Partial bait consumption can result in
tetracycline detection but may be insufficient
for development of an antibody response
(Brown et al. 2012). In our study, the
tetracycline prevalence doubled in adults
and juveniles from 2014 to 2015, but a
corresponding increase in seroprevalence
was not observed. Because ORV baits with
no biomarker were distributed for 14 yr prior
to our study, the cumulative effect of
tetracycline may have been more pro-
nounced compared with the serologic effect
of bait consumption. Disparities between
serologic and tetracycline prevalence pat-
terns could also be attributed to a variety of
factors, such as individual heterogeneity and
environmental or sampling variation.
In another study in which ONRAB was
applied in northern New York, Vermont, and
New Hampshire, the RVNA seroprevalence
was 27% across study cells prior to baiting
with ONRAB (but with previous V-RG
baiting) and averaged 69% after 3 yr of
ONRAB baiting (Gilbert et al. 2018). In rural
West Virginia, seroprevalence (on the basis of
the rapid fluorescent focus inhibition test)
increased from 9.6% in an ORV naı̈ve area
prior to baiting to 49.2% after baiting with
ONRAB for a single year (Slate et al. 2014).
Without accounting for the different serologic
test used in West Virginia, our results
indicated a more modest increase in sero-
prevalence (45.2% prior to baiting and 57.7%
after 3 yr of baiting), but the trend and
amplitude was still higher than the average of
30% often observed after baiting with V-RG
(Slate et al. 2009). The prebait seroprevalence
in 2013 was higher than usual due to elevated
circulation of rabies virus in the county (Fig.
1) and because ORV baiting had occurred for
14 consecutive years prior to the study. The
impact of our study is perhaps more apparent
when focusing on adults, since 73.8% (95%
CI: 67.2–79.5) of adult raccoons were sero-
positive after 3 yr of baiting (Fig. 2). However,
because the average life span of raccoons is
approximately 2–3 yr (Hadidian et al. 2010),
juveniles are assumed to have the most
potential to affect the disease dynamics of
the population. After 3 yr of ONRAB baiting,
the RVNA seroprevalence in the juvenile
cohorts only increased from 35.3% (95% CI:
28.7–42.4) to 40.6 (95% CI: 33.7–47.9).
Targeting juvenile raccoons for ORV uptake
is essential for obtaining the long-term goal of
raccoon rabies elimination.
Skunks can also be infected with the
raccoon rabies virus variant (Guerra et al.
2003). Safe and effective vaccines and baits
for skunks are needed for ultimate rabies
elimination. Although our study was not
designed specifically to evaluate skunks, we
had the opportunity to test 203 skunks, and
the RVNA seroprevalence increased from 4%
(95% CI: 1–18) prior to ONRAB baiting in
2013 to 25% (95% CI: 14–40) after baiting in
2015. This is similar to a study conducted in
Maine and New Brunswick where 3% (n¼36)
and 15% (n¼33) of skunks developed RVNA
(on the basis of competitive enzyme-linked
immunosorbent assay) after baiting with V-
RG and ONRAB, respectively (Fehlner-
Gardiner et al. 2012). In another 3-yr study
conducted in the northeastern US where
ONRAB baits were distributed, the RVNA
seroprevalence in skunks increased from 0%
(n¼4) to 17% (n¼12) in naı̈ve study sites and
from 0 (n¼14) to 18% (n¼55) in areas
previously baited with V-RG (Gilbert et al.
2018). These results suggest that ONRAB may
be a more effective bait for skunks than V-RG,
but additional studies designed to evaluate
skunks are recommended.
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